XML 28 R13.htm IDEA: XBRL DOCUMENT
v3.23.2

Stockholders’ Equity | 12 Months Ended
--- | ---
Jun. 30, 2023
Equity [Abstract] |
Stockholders’ Equity |
6. |  | Stockholders’ Equity
Stock Incentive Plans We have stock incentive plans in effect under which non-qualified and incentive stock options to purchase shares of Lantronix common stock (“stock options”) have been granted to employees, non-employees and board members. In addition, we have previously granted restricted common stock awards (“non-vested shares”) to employees and board members under these plans. In November 2020, our stockholders voted to approve the 2020 Performance Incentive Plan (the “2020 Plan”), replacing our Amended and Restated 2010 Stock Incentive Plan (the “2010 Plan”), which expired in September 2020. At the 2010 Plan’s expiration date, approximately 1,097,000 shares of our common stock that remained available for award grants under the 2010 Plan became available for award grants under the 2020 Plan. An additional 2,500,000 shares our common stock are also available for award grants under the 2020 Plan. In addition, any shares of common stock subject to outstanding awards under the 2010 Plan that expire, are cancelled, or otherwise terminate after the expiration date of the 2010 Plan will be available for award grant purposes under the 2020 Plan. The 2020 Plan authorizes awards of stock options (both non-qualified and incentive), stock appreciation rights, non-vested shares, restricted stock units (“RSUs”) and performance shares (“PSUs”). New shares are issued to satisfy stock option exercises and share issuances. At June 30, 2023, approximately 2,465,000 shares remain available for issuance under the 2020 Plan. We have also granted stock options and RSUs under individual inducement award agreements. The Compensation Committee of our board of directors determines eligibility, vesting schedules and exercise prices for stock options and shares granted under the plans. Stock options are generally granted with an exercise price equal to the market price of our common stock on the grant date. Stock options generally have a contractual term of seven to ten years. Share-based awards generally vest and become exercisable over a one to four-year service period. As of June 30, 2023, no stock appreciation rights or non-vested stock was outstanding. No income tax benefit was realized from activity in the share-based plans during the fiscal years ended June 30, 2023 and 2022. Stock Option Awards The fair value of each stock option grant is estimated on the grant date using the Black-Scholes-Merton option-pricing formula. The expected term of stock options granted is based on our recent historical exercise data. Expected volatilities are based on the historical volatility of our stock price. The risk-free interest rate assumption is based on the U.S. Treasury interest rates appropriate for the expected term of our stock options. The following weighted-average assumptions were used to estimate the fair value of all of our stock option grants:
Schedule of Valuation Assumptions |  |  |  |  |  |  |  |
|  | Years Ended June 30, |
|  | 2023 |  |  | 2022 |
Expected term (in years) |  |  | 3.9 |  |  |  | 4.7 |
Expected volatility |  |  | 62% |  |  |  | 63% |
Risk-free interest rate |  |  | 3.79% |  |  |  | 0.82% |
Dividend yield |  |  | 0.00% |  |  |  | 0.00% |
The following table presents a summary of activity for all of our stock options:
Schedule of option activity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Weighted-Average |  |  |  |
|  |  |  |  | Exercise |  |  | Remaining |  |  | Aggregate |
|  | Number of |  |  | Price |  |  | Contractual |  |  | Intrinsic |
|  | Shares |  |  | Per Share |  |  | Term |  |  | Value |
|  | (In thousands) |  |  |  |  |  | (In years) |  |  | (In thousands) |
Balance of options outstanding at June 30, 2022 |  |  | 1,383 |  |  | $ | 3.40 |  |  |  |  |  |  |  |  |
Granted |  |  | 115 |  |  |  | 4.96 |  |  |  |  |  |  |  |  |
Expired |  |  | (9 | ) |  |  | 2.04 |  |  |  |  |  |  |  |  |
Exercised |  |  | (164 | ) |  |  | 2.55 |  |  |  |  |  |  |  |  |
Balance of options outstanding at June 30, 2023 |  |  | 1,325 |  |  | $ | 3.65 |  |  |  | 2.1 |  |  | $ | 987 |
Options exercisable at June 30, 2023 |  |  | 1,147 |  |  | $ | 3.45 |  |  |  | 1.5 |  |  | $ | 979 |
The following table presents a summary of grant date fair value and intrinsic value information for all of our stock options:
Summary of option grant-date fair value and intrinsic value information |  |  |  |  |  |  |  |
|  | Years Ended June 30, |
|  | 2023 |  |  | 2022 |
|  | (In thousands, except per share data) |
Weighted-average grant date fair value per share |  | $ | 2.44 |  |  | $ | 2.94 |
Intrinsic value of options exercised |  | $ | 454 |  |  | $ | 1,506 |
Restricted Stock Units The fair value of our RSUs is based on the closing market price of our common stock on the grant date. The following table presents a summary of activity with respect to our RSUs:
Summary of other than option activity |  |  |  |  |  |  |  |
|  | Number of Shares |  |  | Weighted-Average Grant Date Fair Value per Share |
|  | (In thousands) |  |  |  |
Balance of RSUs outstanding at June 30, 2022 |  |  | 1,115 |  |  | $ | 5.50 |
Granted |  |  | 763 |  |  |  | 5.59 |
Forfeited |  |  | (96 | ) |  |  | 5.51 |
Vested |  |  | (593 | ) |  |  | 5.22 |
Balance of RSUs outstanding at June 30, 2023 |  |  | 1,189 |  |  | $ | 5.70 |
Performance Shares The following table presents a summary of activity with respect to our PSUs:
Summary of other than option activity |  |  |  |
|  | Number of Shares |
|  | (In thousands) |
Balance of PSUs outstanding at June 30, 2022 |  |  | 1,030 |
Granted |  |  | 1,147 |
Forfeited |  |  | (299 | )
Vested |  |  | (947 | )
Balance of PSUs outstanding at June 30, 2023 |  |  | 931 |
Employee Stock Purchase Plan Our 2013 Employee Stock Purchase Plan (“ESPP”) is intended to provide employees with an opportunity to purchase our common stock through accumulated payroll deductions at the end of a specified purchase period. Each of our employees (including officers) is eligible to participate in our ESPP, subject to certain limitations as set forth in our ESPP. The ESPP currently operates with six month offering periods commencing on the first trading day on or after May 16 and November 16 of each year (an “Offering Period”). Common stock may be purchased under the ESPP at the end of each six-month Offering Period unless the participant withdraws or terminates employment earlier. Shares of the Company’s common stock may be purchased under the ESPP at a price not less than 85% of the lesser of the fair market value of our common stock on the first or last trading day of each Offering Period. The per share fair value of stock purchase rights granted under the ESPP was estimated using the following weighted-average assumptions:
Schedule of Valuation Assumptions |  |  |  |  |  |  |  |
|  | Years Ended June 30, |
|  | 2023 |  |  | 2022 |
Expected term (in years) |  |  | 0.5 |  |  |  | 0.5 |
Expected volatility |  |  | 66% |  |  |  | 59% |
Risk-free interest rate |  |  | 4.88% |  |  |  | 0.92% |
Dividend yield |  |  | 0.00% |  |  |  | 0.00% |
The following table presents a summary of activity under our ESPP:
Summary of other than option activity |  |  |  |
|  | Year Ended June 30, 2023 |
|  | (In thousands, except per share data) |
Shares available for issuance at June 30, 2022 |  |  | 85 |
Shares reserved for issuance |  |  | 500 |
Shares issued |  |  | (204 | )
Shares available for issuance at June 30, 2023 |  |  | 381 |
Weighted-average purchase price per share |  | $ | 4.26 |
Intrinsic value of ESPP shares on purchase date |  | $ | 153 |
Share-Based Compensation Expense The following table presents a summary of share-based compensation expense included in each applicable functional line item on our consolidated statements of operations:
Schedule of share-based compensation expense by functional line item |  |  |  |  |  |  |  |
|  | Years Ended June 30, |
|  | 2023 |  |  | 2022 |
|  | (In thousands) |
Cost of revenues |  | $ | 158 |  |  | $ | 369 |
Selling, general and administrative |  |  | 4,546 |  |  |  | 4,862 |
Research and development |  |  | 1,504 |  |  |  | 1,015 |
Total share-based compensation expense |  | $ | 6,208 |  |  | $ | 6,246 |
The following table presents a summary of the remaining unrecognized share-based compensation expense related to our outstanding share-based awards as of June 30, 2023:
Schedule of unrecognized share-based compensation expense |  |  |  |  |  |  |  |
|  | Remaining Unrecognized Compensation Expense |  |  | Remaining Weighted-Average Years to Recognize |
|  | (In thousands) |  |  |  |
Stock options |  | $ | 402 |  |  |  | 2.6 |
RSUs |  |  | 5,666 |  |  |  | 2.2 |
PSUs |  |  | 1,650 |  |  |  | 1.9 |
Common stock purchase rights under ESPP |  |  | 128 |  |  |  | 0.4 |
|  | $ | 7,846 |  |  |  |  |
If there are any modifications or cancellations of the underlying unvested share-based awards, we may be required to accelerate, increase or cancel remaining unearned share-based compensation expense. Future share-based compensation expense and unearned share-based compensation expense will increase to the extent that we grant additional share-based awards.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration